OXELTIS will be at BIO2026 in San Diego, June 22-25
OXELTIS will be at #BIO2026 in San Diego, June 22-25.We attend as the lead partner of an integrated preclinical R&D consortium, combining medicinal chemistry (OXELTIS, Montpellier), computational CADD/SBDD/GenAI (Molecular Forecaster, Montreal), and preclinical biology (Partex.AI Labs, Regensburg).If you are exploring hit discovery, H2L, or lead optimization partnerships, we would be glad to connect and discuss […]
Oxeltis will be at RICT 2026 in Paris!
We are excited to attend the 60th International Conference on Medicinal Chemistry (Rencontres Internationales de Chimie Thérapeutique), taking place July 1–3, 2026 in Paris, France. Meet our team on site:Christophe Parsy – Business & Strategic Development DirectorGuillaume Laconde PhD – Senior Research ScientistSimon Lamare – Business Development Associate If you’re attending, don’t hesitate to reach […]
Oxeltis is attending the EMFC symposium in Basel
Oxeltis will be at EFMC 2026 in Basel!We are excited to attend the EFMC International Symposium on Medicinal Chemistry, taking place September 6-10, 2026 in Basel, Switzerland. Meet our team on site:Christophe Parsy – Business & Strategic Development DirectorStéphane Salamone – Chemistry Director If you’re attending, don’t hesitate to reach out and schedule a meeting […]